MedPath

Protective Effect of Propofol Against Hemolysis in Patients Submitted to Gastroplasty

Not Applicable
Conditions
Hemolysis
Registration Number
NCT00792779
Lead Sponsor
Centro Medico Campinas
Brief Summary

The purpose of this study is to determine if propofol could protect erythrocytes by directly scavenging free radicals from the blood current and increasing resistance of their cell membranes in patients submitted to gastroplasty.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • patients between BMI 40-50 kg/m2
Exclusion Criteria
  • patients with BMI under 40 kg/m2 and over 50 kg/m2
  • alcohol users
  • illicit-drug users
  • patients in regular use of anti-depressants, proton bomb inhibitors or calcium canal blockers
  • patients transfused either recently, during the intra-operative period or within 10 hours post-operative
  • patients previously known to be hypersensitive to any drug that is used during the study
  • patients with any psychiatric disorder or dementia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Count erythrocytesAfter 10 hours post-surgery
Secondary Outcome Measures
NameTimeMethod
Bilirubins(direct and indirect)After 10 hours post-surgery

Trial Locations

Locations (1)

Fundação Centro Médico de Campinas

🇧🇷

Campinas, São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath